Altria $MO (+1,77%) sells part of its $BUD shares. The value of the investment has now halved ($64) since it was acquired ($127). Altria intends to use the proceeds to buy back its own shares. In my opinion, this is yet another bad decision by the management. $BUD It joins the ranks of the flawed JUUL and Cronos investments. To now sell shares in an investment that was previously defended and was supposed to provide long-term shareholder value in order to relieve the company's own share price in the short term resembles an act of desperation. Moreover, they could not even bring themselves to sell the entire package, which they should never have acquired.

For me, this confirms once again why I sold Altria.